Who Certification Scheme On The Quality Of Pharmaceutical Products

By Amabella Pelland • Published: 08 September 2023 • Updated: 12 May 2025

Some National and Regional Regulatory Authorities have indicated that, during the COVID-19 crisis, they will no longer be in a position to issue and send paper copies of Certificates issued in the context of WHO Certification scheme on the quality of pharmaceutical.

Certificate of a pharmaceutical product This certificate conforms to the format recommended by the World Health Organization No. of certificate Exporting (certifying country):.

The WHO Certification Scheme for a Certificate of Pharmaceutical Product (CPP) is an international voluntary agreement to provide assurance to countries participating in the.

The World Health Organization (WHO) Certification Scheme was initially implemented to accelerate the availability of new drugs in developing countries by.

The WHO Certification Scheme for a Certificate of Pharmaceutical Product (CPP) is an international voluntary agreement to provide assurance to countries.

Regulatory convergence & networks / Certification scheme / Requesting a certificate Guidelines on the Implementation of the WHO certification scheme on the quality of.

Health Organization (WHO) Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce in 1975. The Scheme has been revised twice since.

Contacts list Competent authorities of countries participating in the WHO certification scheme on the quality of pharmaceutical products moving in international commerce..

This system verifies the authenticity of an electronic certificate issued by EMA on behalf of the European Commission, under the World Health Organization certification scheme on.

World Health Organization. Division of Drug Management and Policies. (‎1997)‎. WHO certification scheme on the quality of pharmaceutical products moving in international.

proposed scheme and its application differ in certain aspects from the scheme for pharmaceutical products, namely, in the provision made for alternative quality assurance.

259 258 1.A10 Yes, there are published guidelines called “Guidelines for implementation of the 260 WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in.

WHO Action Programme on Essential Drugs. (‎1995)‎. Use of the WHO certification scheme on the quality of pharmaceutical products moving in international commerce. World.

To facilitate use of the World Health Organisation (WHO) Certification Scheme, a set of guidelines was developed in 1996, which includes model certificates.

To facilitate use of the World Health Organisation (WHO) Certification Scheme, a set of guidelines was developed in 1996, which includes model certificates for use by Member.

WHO certification scheme on the quality of pharmaceutical products moving in international commerce : with an updated list of participating countries, Rev. 5..

of the WHO Certification Scheme on the quality of pharmaceutical products moving in international commerce in resolution WHA22.50, it accepted at the same time the GMP.

WHO certification scheme on the quality of pharmaceutical products moving in international commerce. The certificate shall detail the agreed specifications of the product, the.

Guidelines on the Implementation of the WHO certification scheme on the quality of pharmaceutical products moving in international commerce Eligibility for participation 2.1.

The WHO Certification Scheme for finished pharmaceutical products is an international voluntary agreement to provide assurance to countries participating in the Scheme,.

CMPs are issued in the framework of the World Health Organisation (WHO) certification scheme on the quality of pharmaceutical products moving in international commerce..